AutoZone (AZO) Gets a Buy from Oppenheimer

Oppenheimer kept an Outperform rating on AutoZone with a $3500 price target, suggesting 23.1% upside from the Sep 17 close. The firm cites strategic investments to boost market share and a low forward PE multiple of 16x as reasons for the positive outlook.

Oppenheimer upgraded Etsy (ETSY) to Outperform with a $90 price target, citing AI-driven search improvements and stronger user engagement. The stock rose 2.9% in premarket trading. Analyst Jason Helfstein noted positive third-quarter traffic data and high direct traffic levels, suggesting a competitive advantage. Etsy raised its full-year GMS growth outlook to a mid-single-digit range.

UBS suggests AutoZone's earnings could grow to mid-teens EPS by fiscal 2027, despite a lower Q4 estimate of $52.19 vs. consensus $54.42. The firm cites accounting methods, store maturation, and expense growth as factors. Gross margin of 51.7% is noted as significant.

Oppenheimer increased its price target for Definium Therapeutics (DFTX) to $75 from $70, maintaining an Outperform rating. The firm cited positive Phase 3 trial results for DT120, which it believes support the company's potential to improve treatment for GAD patients. Oppenheimer updated its model to reflect increased optimism.

AutoZone (AZO), a large-cap auto parts retailer, has underperformed peers like Genuine Parts (GPC) with a 30.1% drop over 52 weeks, trading below key moving averages. Q3 2026 revenue missed estimates at $4.8B, but EPS beat at $38.07. Analysts rate it 'Strong Buy' with a $3,935.96 target, implying 32.4% upside.

Oppenheimer maintained an 'Outperform' rating for Target Hospitality Corp (TH) and raised its price target from $24 to $27. The company's GF Value™ indicates a 144.9% overvaluation, with a GF Score™ of 66/100. TH operates in specialty rental and hospitality services, with a market cap of $2.02 billion. Analysts remain optimistic despite valuation concerns.